The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
This study has been completed.
First Posted: July 9, 2013
Last Update Posted: October 30, 2015
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2014|
|Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||September 21, 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Bays HE, Hallén J, Vige R, Fraser D, Zhou R, Hustvedt SO, Orloff DG, Kastelein JJ. Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial. J Clin Lipidol. 2016 Jan-Feb;10(1):181-91.e1-2. doi: 10.1016/j.jacl.2015.10.012. Epub 2015 Nov 14.